Oramed Pharmaceuticals Total Assets 2011-2025 | ORMP
Oramed Pharmaceuticals total assets from 2011 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
Oramed Pharmaceuticals Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $155 |
| 2023 | $221 |
| 2022 | $162 |
| 2021 | $178 |
| 2021 | $128 |
| 2020 | $45 |
| 2019 | $35 |
| 2018 | $47 |
| 2017 | $39 |
| 2016 | $43 |
| 2015 | $26 |
| 2014 | $22 |
| 2013 | $9 |
| 2012 | $0 |
| 2012 | $5 |
| 2011 | $0 |
| 2011 | $4 |
| 2010 | $4 |
|
Oramed Pharmaceuticals Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-06-30 | $162 |
| 2025-03-31 | $148 |
| 2024-12-31 | $155 |
| 2024-09-30 | $165 |
| 2024-06-30 | $184 |
| 2024-03-31 | $204 |
| 2023-12-31 | $221 |
| 2023-09-30 | $231 |
| 2023-06-30 | $156 |
| 2023-03-31 | $160 |
| 2022-12-31 | $162 |
| 2022-09-30 | $164 |
| 2022-06-30 | $162 |
| 2022-03-31 | $172 |
| 2021-12-31 | $178 |
| 2021-11-30 | $182 |
| 2021-09-30 | $0 |
| 2021-08-31 | $128 |
| 2021-06-30 | $0 |
| 2021-05-31 | $80 |
| 2021-03-31 | $0 |
| 2021-02-28 | $62 |
| 2020-11-30 | $41 |
| 2020-08-31 | $45 |
| 2020-05-31 | $46 |
| 2020-02-29 | $30 |
| 2019-11-30 | $31 |
| 2019-08-31 | $35 |
| 2019-05-31 | $37 |
| 2019-02-28 | $42 |
| 2018-11-30 | $44 |
| 2018-08-31 | $47 |
| 2018-05-31 | $35 |
| 2018-02-28 | $38 |
| 2017-11-30 | $42 |
| 2017-08-31 | $39 |
| 2017-05-31 | $40 |
| 2017-02-28 | $42 |
| 2016-11-30 | $45 |
| 2016-08-31 | $43 |
| 2016-05-31 | $36 |
| 2016-02-29 | $38 |
| 2015-11-30 | $24 |
| 2015-08-31 | $26 |
| 2015-05-31 | $22 |
| 2015-02-28 | $23 |
| 2014-11-30 | $25 |
| 2014-08-31 | $22 |
| 2014-05-31 | $22 |
| 2014-02-28 | $24 |
| 2013-11-30 | $8 |
| 2013-08-31 | $9 |
| 2013-05-31 | $5 |
| 2013-02-28 | $6 |
| 2012-12-31 | $0 |
| 2012-11-30 | $7 |
| 2012-08-31 | $5 |
| 2012-05-31 | $2 |
| 2012-02-29 | $3 |
| 2011-11-30 | $4 |
| 2011-09-30 | $1 |
| 2011-08-31 | $4 |
| 2011-06-30 | $0 |
| 2011-05-31 | $0 |
| 2011-03-31 | $0 |
| 2011-02-28 | $0 |
| 2010-12-31 | $0 |
| 2010-11-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.092B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.559B | 24.96 |
| EssilorLuxottica (ESLOY) | France | $168.705B | 0.00 |
| Boston Scientific (BSX) | United States | $146.614B | 33.53 |
| Stryker (SYK) | United States | $136.781B | 27.16 |
| Medtronic (MDT) | Ireland | $115.955B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.709B | 0.00 |
| Agilent Technologies (A) | United States | $41.609B | 26.93 |
| ResMed (RMD) | United States | $35.788B | 24.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.442B | 16.47 |
| Koninklijke Philips (PHG) | Netherlands | $27.029B | 17.65 |
| Terumo (TRUMY) | Japan | $24.148B | 28.61 |
| Insulet (PODD) | United States | $22.134B | 74.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.343B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.690B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.227B | 7.45 |
| Bio-Rad Laboratories (BIO) | United States | $8.390B | 30.07 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.891B | 10.52 |
| Envista Holdings (NVST) | United States | $3.313B | 19.01 |
| ICU Medical (ICUI) | United States | $3.144B | 21.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.944B | 13.06 |
| Haemonetics (HAE) | United States | $2.444B | 10.91 |
| Perrigo (PRGO) | Ireland | $2.078B | 5.21 |
| LeMaitre Vascular (LMAT) | United States | $1.953B | 41.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.917B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.858B | 11.95 |
| Phibro Animal Health (PAHC) | United States | $1.668B | 16.66 |
| AtriCure (ATRC) | United States | $1.607B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.437B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.421B | 62.27 |
| AdaptHealth (AHCO) | United States | $1.399B | 20.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.363B | 0.00 |
| Neogen (NEOG) | United States | $1.349B | 25.88 |
| BioLife Solutions (BLFS) | United States | $1.321B | 2757.00 |
| InMode (INMD) | Israel | $0.918B | 10.38 |
| Valneva SE (VALN) | France | $0.774B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.492B | 16.94 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Evolus (EOLS) | United States | $0.441B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.384B | 0.00 |
| Brainsway (BWAY) | Israel | $0.307B | 62.19 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.278B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.273B | 0.00 |
| High Tide (HITI) | Canada | $0.263B | 0.00 |
| Owens & Minor (OMI) | United States | $0.259B | 2.60 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 148.67 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.49 |
| Sanara MedTech (SMTI) | United States | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| Exagen (XGN) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.222B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.210B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.38 |
| FitLife Brands (FTLF) | United States | $0.184B | 22.66 |
| Biote (BTMD) | United States | $0.145B | 5.86 |
| Sharps Technology (STSS) | United States | $0.119B | 0.00 |
| Apyx Medical (APYX) | United States | $0.119B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.99 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Nephros (NEPH) | United States | $0.060B | 47.42 |
| ImmuCell (ICCC) | United States | $0.057B | 33.16 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 12.50 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |